CO-EVOLVED MOLECULES Trademark

Trademark Overview

On Friday, March 26, 2021, a trademark application was filed for CO-EVOLVED MOLECULES with the United States Patent and Trademark Office. The USPTO has given the CO-EVOLVED MOLECULES trademark a serial number of 90605032. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, May 21, 2025. This trademark is owned by Empress Therapeutics, Inc.. The CO-EVOLVED MOLECULES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
co-evolved molecules

General Information

Serial Number90605032
Word MarkCO-EVOLVED MOLECULES
Filing DateFriday, March 26, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, May 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
NOT AVAILABLE"MOLECULES"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmpress Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameEmpress Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Thursday, July 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 4, 2021ASSIGNED TO EXAMINER
Friday, November 5, 2021NON-FINAL ACTION WRITTEN
Friday, November 5, 2021NON-FINAL ACTION E-MAILED
Friday, November 5, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 24, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 24, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 24, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 29, 2021FINAL REFUSAL WRITTEN
Monday, November 29, 2021FINAL REFUSAL E-MAILED
Monday, November 29, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, May 9, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, May 9, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 14, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 9, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 25, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 14, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, February 6, 2023SOU EXTENSION 1 FILED
Monday, February 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, February 6, 2023SOU EXTENSION 1 GRANTED
Wednesday, February 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 6, 2024SOU EXTENSION 3 GRANTED
Thursday, August 3, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 3, 2023SOU EXTENSION 2 FILED
Thursday, August 3, 2023SOU EXTENSION 2 GRANTED
Saturday, August 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 6, 2024SOU EXTENSION 3 FILED
Thursday, February 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2024SOU EXTENSION 4 FILED
Sunday, February 9, 2025SOU EXTENSION 5 FILED
Monday, February 10, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, May 21, 2025SOU EXTENSION 5 GRANTED
Wednesday, May 21, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 22, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2024SOU EXTENSION 4 GRANTED

Related Keywords

molecules evolved disorders diseases related endocrinological metabolic neurodegenerative neurological system immune therapeutic